Suchergebnisse - "Albanell, J"

PubPharm (197)

1

Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer : GEICAM/2014-12 (FLIPPER)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Albanell, J. | Martínez, M. | Ramos, M. | +17

2

Correction to : Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2018

von Colomer, R. | Aranda-López, I. | Albanell, J. | +7

ErratumFor: Clin Transl Oncol. 2018 Jul;20(7):815-826. - PMID 29273958

3

Biomarkers in breast cancer : A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2018

von Colomer, R. | Aranda-López, I. | Albanell, J. | +7

ErratumIn: Clin Transl Oncol. 2018 Jun 18;:. - PMID 29916189

4

Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

enthalten in: Revista de oncología | 2018

von Colomer, R. | Aranda-López, I. | Albanell, J. | +7

5

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

enthalten in: Oncoimmunology | 2018

von Hardy-Werbin, M. | Arpí, O. | Taus, A. | +10

6

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

enthalten in: Revista de oncología | 2017

von Colomer, R. | Aranda-López, I. | Albanell, J. | +7

7

CIP2A confirms its prognostic value in triple-negative breast cancer

enthalten in: Oncogene | 2017

von Cristóbal, I. | Zazo, S. | Torrejón, B. | +8

CommentOn: Oncogene. 2017 Apr 6;36(14 ):1952-1964. - PMID 27694903

8

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Vidal, J. | Muinelo, L. | Dalmases, A. | +18

9

A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer : an expert consensus of the Spanish Society of Medical Oncology (SEOM)

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2017

von González, A. | Lluch, A. | Aba, E. | +18

10

A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

enthalten in: Clinical & translational oncology | 2017

von González, A. | Lluch, A. | Aba, E. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]